EUCAST快速纸片扩散法直接用于阳性血培养瓶的药敏试验
EUCAST开发了基于纸片扩散法的快速药敏试验(RAST),直接在阳性血培养瓶上操作,4-8小时可报告结果。研究用332株临床分离株(7种脓毒症相关病原体)验证,结果可解释比例从4小时的75%升至8小时的84%,分类一致性好,假敏感率0.2%,假耐药率0.1%-1.2%。同时引入技术不确定区域以减少误差。
要点
- RAST可在血培养阳性后4-8小时提供可靠药敏结果,覆盖7种重要血流感染病原体。
- 结果可解释比例4小时75%、8小时84%,假敏感率0.2%,假耐药率0.1%-1.2%。
- 引入技术不确定区域以吸收非标准化接种量、不同厂商耗材和工作流程延迟带来的变异。
核心结论
- EUCAST RAST法可在血培养阳性后4-8小时内为7种重要血流感染病原体提供可靠药敏结果。
研究设计与样本
- 用332株临床分离株(7种最常见脓毒症病原体,含多种耐药机制)接种血培养瓶,直接进行纸片扩散法,于4、6、8小时读取抑菌圈。
- 研究变量包括不同血培养瓶品牌及阳性信号后0-18小时延迟进行RAST的影响。
主要发现
- 5个菌种的大部分抑菌圈可在4小时读取。
- 可解释结果比例从4小时的75%增至8小时的84%。
- 与参考方法比较,假敏感率在4、6、8小时均为0.2%;假耐药率分别为1.2%、0.2%、0.1%。
关键数值与推荐
- 分类一致性良好,假敏感率0.2%(4、6、8小时),假耐药率1.2%(4小时)、0.2%(6小时)、0.1%(8小时)。
- 设立技术不确定区域,该区域内不允许解释结果。
临床怎么用
- 对血培养阳性患者,可在4-8小时内直接进行纸片扩散法药敏试验,提前报告结果。
- 需注意技术不确定区域,避免在该区域解释结果以减少误差。
局限性
- 非标准化接种量、不同厂商耗材及工作流程延迟可导致变异,需通过技术不确定区域吸收。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: With increasing antimicrobial resistance, rapid antimicrobial susceptibility testing (RAST) becomes important, especially in patients with bloodstream infections. EUCAST decided to develop a standardized rapid method, based on EUCAST disc diffusion, to offer susceptibility reports within 4-8 h of a positive blood culture (BC). METHODS: BC bottles were spiked with clinical isolates (n = 332) of the seven most relevant sepsis pathogens with a variety of resistance mechanisms. RAST was performed directly from the bottle and zones read after 4, 6 and 8 h. Several variables were investigated, including the effect of using different BC bottles and of a 0-18 h delay between a positive signal and the performance of RAST. RESULTS: For five species, most inhibition zones could be read after 4 h. The proportion of results that could be interpreted increased from 75% at 4 h to 84% after 8 h. Categorical agreement against the reference method was good, with error rates of false susceptibility of 0.2%, 0.2% and 0.2% at 4, 6 and 8 h and false resistance of 1.2%, 0.2% and 0.1% at 4, 6 and 8 h, respectively. CONCLUSIONS: With the EUCAST RAST method, reliable AST results can be delivered within 4-8 h of positivity of BC bottles for seven important bloodstream infection pathogens. To reduce the occurrence of errors and to absorb the variability caused by using a non-standardized inoculum, material from different manufacturers and workflow-related delays, we have introduced an area in which interpretation is not permitted, the Area of Technical Uncertainty.
引用
- Jonasson E, Matuschek E, Kahlmeter G, et al. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother. 2020. PMID: 32016342. doi:10.1093/jac/dkz548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。